Definitely keen to get more of this ETF. I suspect there could be a huge fallout post the Covid/vaccines of cancers.
Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib, page-14
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $2.148K | 537.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 3926895 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 17489088 | 18 |
View Market Depth
| Last trade - 11.52am 30/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |